background avian influenza ahn threaten human health nearly dead vaccine without adj poorly immunogen flexible rapid tactic mass vaccine need tandem occur method multicent random blind phase clinic trial value safety antibody response pointofus mix indonesia hn mf fields pharmacy mix mcg antigen prior intramuscular administer day health adult age year result two under seventh subject enroll tier hemagglutin inhibit achieve receive v p peak geometry mean regardless dose neutral fold higher product crossreact heterolog virus excel tower demons concur target high percentage safe feasible studi 